Intrathecal substance P-induced thermal hyperalgesia and spinal release of prostaglandin E2 and amino acids

scientific article published on March 1999

Intrathecal substance P-induced thermal hyperalgesia and spinal release of prostaglandin E2 and amino acids is …
instance of (P31):
scholarly articleQ13442814

External links are
P356DOI10.1016/S0306-4522(98)00488-6
P698PubMed publication ID10077333

P2093author name stringP Chen
T L Yaksh
X Y Hua
M Marsala
P2860cites workNociceptive effects induced by intrathecal administration of prostaglandin D2, E2, or F2 alpha to conscious miceQ28334553
A new and sensitive method for measuring thermal nociception in cutaneous hyperalgesiaQ29620385
Characterization of inducible cyclooxygenase in rat brainQ33593129
Molecular characterization of a functional cDNA encoding the rat substance P receptorQ33891305
Effect of bradykinin and prostaglandins on the release of calcitonin gene‐related peptide‐like immunoreactivity from the rat spinal cord in vitroQ35870977
A cure for wind up: NMDA receptor antagonists as potential analgesicsQ37890801
Activation of protein kinase C promotes glutamate-mediated transmission at the neuromuscular junction of the mealwormQ38596828
Slow excitatory transmission in rat dorsal horn: possible mediation by peptidesQ39341067
Modulation of spinal excitability: co-operation between neurokinin and excitatory amino acid neurotransmittersQ39370851
Injury-induced plasticity of spinal reflex activity: NK1 neurokinin receptor activation and enhanced A- and C-fiber mediated responses in the rat spinal cord in vitroQ39402486
The physiology of excitatory amino acids in the vertebrate central nervous systemQ39462515
Excitatory Amino Acid TransmittersQ40084320
Substance P: Localization in the Central Nervous System and in Some Primary Sensory NeuronsQ40349945
Temperature dependency of basal and evoked release of amino acids and calcitonin gene-related peptide from rat dorsal spinal cordQ40650540
Nitric oxide (NO) and nociceptive processing in the spinal cordQ40887811
Peptides and the primary afferent nociceptorQ40911083
The origin, distribution and synaptic relationships of substance P axons in rat spinal cordQ40993620
Extracellular amino acid concentrations in the dorsal spinal cord of freely moving rats following veratridine and nociceptive stimulationQ41346813
Prostaglandin E2 enhances bradykinin-stimulated release of neuropeptides from rat sensory neurons in culture.Q41662482
Prostaglandins inhibit endogenous pain control mechanisms by blocking transmission at spinal noradrenergic synapsesQ42200367
Prostaglandin E2 increases calcium conductance and stimulates release of substance P in avian sensory neuronsQ42454277
Distribution and characterization of cyclooxygenase immunoreactivity in the ovine brainQ43664339
Effect of substance P in cat dorsal horn neurones activated by noxious stimuliQ43689036
Capsaicin-evoked prostaglandin E2 release in spinal cord slices: relative effect of cyclooxygenase inhibitorsQ44225100
Sustained potentiation of NMDA receptor-mediated glutamate responses through activation of protein kinase C by a μ opioidQ44335232
Substance P and Spinal NeuronesQ44488291
Cyclooxygenase inhibition and the spinal release of prostaglandin E2 and amino acids evoked by paw formalin injection: a microdialysis study in unanesthetized rats.Q44603003
Noxious stimulus-induced increase in spinal prostaglandin E2 is noradrenergic terminal-dependentQ44608700
Antinociceptive effect of taurine and its inhibition by naxoloneQ44911020
Leukotriene and prostaglandin sensitization of cutaneous high-threshold C- and A-delta mechanonociceptors in the hairy skin of rat hindlimbs.Q45989015
Stereospecific effects of a nonpeptidic NK1 selective antagonist, CP-96,345: Antinociception in the absence of motor dysfunctionQ46008800
Antinociception produced by spinal delivery of the S and R enantiomers of flurbiprofen in the formalin testQ46135927
Hyperalgesia mediated by spinal glutamate or substance P receptor blocked by spinal cyclooxygenase inhibitionQ46223466
The spinal loop dialysis catheter: characterization of use in the unanesthetized rat.Q46510308
Neonatal capsaicin treatment abolishes formalin-induced spinal PGE2 releaseQ46601601
Formalin-evoked activity in identified primary afferent fibers: systemic lidocaine suppresses phase-2 activityQ46914865
Glutamate-like immunoreactive structures in primary sensory neurons in the rat detected by a specific antiserum against glutamateQ48258041
Increase in substance P in the dorsal horn during a chemogenic nociceptive stimulusQ48470698
Protein kinase C reduces Mg2+ block of NMDA-receptor channels as a mechanism of modulationQ48493712
A role for taurine in the maintenance of homeostasis in the central nervous system during hyperexcitation?Q48589494
Release of substance P into the superficial dorsal horn following nociceptive activation of the hindpaw of the ratQ48607741
Neurotransmitter candidates of somatosensory primary afferent fibresQ48712380
Amino terminus of substance P potentiates kainic acid-induced activity in the mouse spinal cordQ48826416
Characteristics of substance P-evoked release of amino acids from neonatal rat spinal cord.Q51596606
Spinal cord amino acid release and content in an arthritis model: the effects of pretreatment with non-NMDA, NMDA, and NK1 receptor antagonists.Q51650419
Inflammatory pain hypersensitivity mediated by phenotypic switch in myelinated primary sensory neurons.Q52198922
Excitatory amino acid-mediated components of synaptically evoked input from dorsal roots to deep dorsal horn neurons in the rat spinal cord slice.Q54340704
Intrathecal morphine inhibits substance P release from mammalian spinal cord in vivoQ59061346
The effect of intrathecal administration of RP67580, a potent neurokinin 1 antagonist on nociceptive transmission in the rat spinal cordQ60679697
Antinociceptive effects of intrathecal taurine and calcium in the mouseQ67536791
Modulation of excitatory amino acid responses in rat dorsal horn neurons by tachykininsQ67542207
Tachykinins and calcitonin gene-related peptide enhance release of endogenous glutamate and aspartate from the rat spinal dorsal horn sliceQ67661642
Interactions between substance P, calcitonin gene-related peptide, taurine and excitatory amino acids in the spinal cordQ67675192
Characterization of the hyperalgesic effect induced by intrathecal injection of substance PQ68938608
Stimulus specificity of peripherally evoked substance P release from the rabbit dorsal horn in situQ69084852
Dissociation between antinociceptive and anti-inflammatory effects of acetylsalicylic acid and indomethacin in the formalin testQ69528189
Up-regulation of cyclooxygenase-2 mRNA in the rat spinal cord following peripheral inflammationQ71256145
Characterization of time course of spinal amino acids, citrulline and PGE2 release after carrageenan/kaolin-induced knee joint inflammation: a chronic microdialysis studyQ71852011
Prostaglandins facilitate peptide release from rat sensory neurons by activating the adenosine 3',5'-cyclic monophosphate transduction cascadeQ71924140
Thermal hyperalgesia in rat evoked by intrathecal substance P at multiple stimulus intensities reflects an increase in the gain of nociceptive processingQ71940261
Involvement of substance P and neurokinin-1 receptors in the hyperexcitability of dorsal horn neurons during development of acute arthritis in rat's knee jointQ71978632
Neuropharmacological characterization of SR 140333, a non peptide antagonist of NK1 receptorsQ72071706
Brain-derived neurotrophic factor is induced as an immediate early gene following N-methyl-D-aspartate receptor activationQ72259523
Neurokinin 1 and 2 antagonists attenuate the responses and NK1 antagonists prevent the sensitization of primate spinothalamic tract neurons after intradermal capsaicinQ72413267
Behavioral evidence that substance P may be a spinal cord sensory neurotransmitterQ72633469
Substance P reduces tail-flick latency: implications for chronic pain syndromesQ72685061
Sensitization of peripheral afferent fibres in the in vitro neonatal rat spinal cord-tail by bradykinin and prostaglandinsQ72844995
Spontaneous and evoked release of prostaglandins from frog spinal cordQ72883308
P433issue2
P407language of work or nameEnglishQ1860
P921main subjectprostaglandin E2Q416554
P1104number of pages10
P304page(s)525-534
P577publication date1999-03-01
P1433published inNeuroscienceQ15708571
P1476titleIntrathecal substance P-induced thermal hyperalgesia and spinal release of prostaglandin E2 and amino acids
P478volume89

Reverse relations

cites work (P2860)
Q41780863Acetaminophen prevents hyperalgesia in central pain cascade
Q34515061Activated microglia contribute to the maintenance of chronic pain after spinal cord injury.
Q36449385Activation of the neurokinin-1 receptor by substance P triggers the release of substance P from cultured adult rat dorsal root ganglion neurons
Q40735769Altered spinal arachidonic acid turnover after peripheral nerve injury regulates regional glutamate concentration and neuropathic pain behaviors in rats
Q42126244Blockade and reversal of spinal morphine tolerance by peptide and non-peptide calcitonin gene-related peptide receptor antagonists
Q42792495Changes in Tissue Substance P Levels in Patients With Carpal Tunnel Syndrome
Q47596315Contribution of neurokinin 1 receptors in the cutaneous orofacial inflammatory pain
Q40563340Delivery of Alginate Scaffold Releasing Two Trophic Factors for Spinal Cord Injury Repair.
Q43298954Effect of memantine on the levels of neuropeptides and microglial cells in the brain regions of rats with neuropathic pain
Q33784210Functional neurokinin and NMDA receptor activity in an animal naturally lacking substance P: the naked mole-rat
Q35028598In vitro prostanoid release from spinal cord following peripheral inflammation: effects of substance P, NMDA and capsaicin
Q44597452Inhibition of neurokinin-1-substance P receptor and prostanoid activity prevents and reverses the development of morphine tolerance in vivo and the morphine-induced increase in CGRP expression in cultured dorsal root ganglion neurons
Q46973494Inhibition of spinal protein kinase C blocks substance P-mediated hyperalgesia
Q37900692Long-term consequences of chronic pain: mounting evidence for pain as a neurological disease and parallels with other chronic disease states
Q52290421Managing chronic-pain patients in the new millennium: clinical basis and regulatory viewpoint from Texas, U.S.A.
Q34199035Prostaglandins and cyclooxygenases [correction of cycloxygenases] in the spinal cord
Q44000335Role for both spinal cord COX-1 and COX-2 in maintenance of mechanical hypersensitivity following peripheral nerve injury
Q34183893Role of prostaglandins in spinal transmission of the exercise pressor reflex in decerebrated rats
Q40771606Role of spinal p38alpha and beta MAPK in inflammatory hyperalgesia and spinal COX-2 expression
Q43263235Spinal administration of lipoxygenase inhibitors suppresses behavioural and neurochemical manifestations of naloxone-precipitated opioid withdrawal
Q43792449Spinal prostaglandins are involved in the development but not the maintenance of inflammation-induced spinal hyperexcitability.
Q33216935Substance P inhibits progesterone conversion to neuroactive metabolites in spinal sensory circuit: a potential component of nociception
Q48617592Substance P initiates NFAT-dependent gene expression in spinal neurons
Q43697187The acute antihyperalgesic action of nonsteroidal, anti-inflammatory drugs and release of spinal prostaglandin E2 is mediated by the inhibition of constitutive spinal cyclooxygenase-2 (COX-2) but not COX-1.
Q34746394The neuropharmacology of centrally-acting analgesic medications in fibromyalgia
Q24677387The role of spinal neuropeptides and prostaglandins in opioid physical dependence
Q33679499The spinal biology in humans and animals of pain states generated by persistent small afferent input
Q35656935Up-Regulation of the Biosynthesis and Release of Substance P through Wnt/β-Catenin Signaling Pathway in Rat Dorsal Root Ganglion Cells